According to the Alzheimer’s Association, an estimated 6.5 million Americans aged 65 and older are living with Alzheimer’s in 2022. That figure is predicted to nearly double by 2050.
In a recent study published in Nature Neuroscience, the researchers explain how their noninvasive treatment delivered through electrodes in a wearable cap can improve memory function in older adults and gets us one step closer to providing a more efficient treatment for memory loss.
The senior author explains his research, findings, and potential impact in the Q&A below.
What did your study find?
We delivered our noninvasive treatment to target memory function through scalp electrodes and found that electrical brain stimulation for 20 minutes on four consecutive days can improve working memory and long-term memory in individuals 65 years and older for at least one month.
Low-frequency electrode activity improved working memory on day three and day four and one month after intervention, on the other hand, high-frequency improved long-term memory on days two–four and one month after intervention. Our findings demonstrate that the plasticity of the aging brain can be selectively and sustainably altered using these two treatments.
How does this paper expand on your previous study with electrostimulation treatment for memory loss?
In this new study, we used multiple, consecutive days of stimulation for 20 minutes to cause long-lasting memory improvements that lasted one month. Previously, the effects lasted only 50 minutes.
Another important difference is that in this recent study we developed two brain stimulation protocols — one for selectively improving short-term memory via low-frequency parietal stimulation, and another protocol for selectively improving long-term memory via high-frequency prefrontal stimulation.
What are the real-world implications of these findings?
An increasingly older population leads to additional personal, social, healthcare and economic costs. A factor greatly contributing to these costs is the impairment in basic memory systems essential for activities of everyday life, such as making financial decisions or understanding language.
Memory decline varies in severity across individuals during aging, with a rapid decline potentially predicting Alzheimer’s disease and other dementias.
Existing therapeutic approaches for impaired cognition are limited by mixed treatment outcomes, slow improvement, and accompanying risks and side effects. For those reasons, there’s an urgent need to develop innovative therapeutic interventions that can provide rapid and sustainable improvements with minimal side effects.
Clinically, this is important because there are people with only short-term memory problems and others with only long-term memory problems. So, having tools in hand that can address each of these memory systems is of great value.
What’s next?
Further research is needed to determine whether these effects can last beyond one month and whether these specific methods can also enhance memory function in individuals with impaired cognition due to brain disorders and in those at risk for dementia.
https://www.nature.com/articles/s41593-022-01132-3
http://sciencemission.com/site/index.php?page=news&type=view&id=publications%2Flong-lasting&filter=22
Can we reverse the effects of age related memory loss?
- 762 views
- Added
Edited
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Mouse pups with human mutation show signs of stuttering
Read more
Mechanism behind brains derailed train of thought
Read more
Effect of progressive weight loss on metabolic functions
Read more
Alcohol exposure during pregnancy affects multiple generations
Read more
Dysregulation of miRNA-9 in a Subset of Schizophrenia Patient-Deriv…
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar